Stock Research: VITA 34

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

VITA 34

XTRA:V3V DE000A0BL849
4
  • Value
    21
  • Growth
    71
  • Safety
    Safety
    10
  • Combined
    8
  • Sentiment
    1
  • 360° View
    360° View
    4
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

FamiCord AG is a medical technology company and cell/stem bank involved in long-term storage and processing of stem cells from umbilical cord blood for disease treatment and regenerative medicine. Its main business is long-term storage and processing of stem cells from human umbilical cord blood and research activities around regenerative medicine. The company operates in Germany, Spain, and Denmark. In the last fiscal year, the company had a market cap of $101 million, profits of $30 million, revenue of $85 million, and 771 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 4 (better than 4% compared with alternatives), overall professional sentiment and financial characteristics for the stock VITA 34 are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for VITA 34. The consolidated Growth Rank has a good rank of 71, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. It ranks higher than 71% of competitors in the same industry. The other indicators are below average, namely the Value, Safety, and Sentiment Ranks.The Value Rank at 10 means that the share price of VITA 34 is on the high side compared with its peers regarding revenues, profits, and invested capital. The stock price is higher than for 90% of alternative stocks in the same industry. The consolidated Safety Rank has a riskier rank of 21, which means that the company has a riskier financing structure than 79% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. The consolidated Sentiment Rank also has a low rank of 1, indicating professional investors are more pessimistic about the stock than for 99% of alternative investment opportunities. ...read more

more
Index
CDAX
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
10 57 16 42
Growth
71 32 35 79
Safety
Safety
21 4 4 38
Sentiment
1 35 16 68
360° View
360° View
4 9 1 64
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
5 100 13 100
Opinions Change
50 50 50 50
Pro Holdings
n/a 30 23 1
Market Pulse
12 5 56 69
Sentiment
1 35 16 68
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
10 57 16 42
Growth
71 32 35 79
Safety Safety
21 4 4 38
Combined
8 12 1 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
3 43 1 25
Price vs. Earnings (P/E)
70 93 84 71
Price vs. Book (P/B)
14 59 32 79
Dividend Yield
1 1 1 1
Value
10 57 16 42
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
58 17 19 30
Profit Growth
90 81 96 82
Capital Growth
14 50 41 92
Stock Returns
73 26 18 58
Growth
71 32 35 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
23 19 10 55
Refinancing
10 4 3 22
Liquidity
26 21 14 45
Safety Safety
21 4 4 38

Similar Stocks

Discover high‑ranked alternatives to VITA 34 and broaden your portfolio horizons.

KSB

XTRA:KSB
Country: Germany
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

Continental

XTRA:CON
Country: Germany
Industry: Auto Parts & Equipment
Size: X-Large
Full Stock Analysis

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.